Transition from agalsidase beta to migalastat in a female Fabry disease patient with recurrent stroke-like episodes

被引：0
|
作者：
Wang, Hua [1 ]
机构：
[1] Loma Linda Univ, Sch Med, Loma Linda, CA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2023.108071
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
332
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Successful treatment using agalsidase alfa of a patient with Fabry disease who had anaphylaxis after agalsidase beta: A case report
    Cakmak, Mehmet Erdem
    NORTHERN CLINICS OF ISTANBUL, 2024, 11 (01) : 88 - 90
  • [42] Vascular involvement in a patient with mitochondrial myopathy, encephalopathy lactic acidosis, and stroke-like episodes
    Takahashi, N
    Shimada, T
    Murakami, Y
    Katoh, H
    Oyake, N
    Ishibashi, Y
    Nishino, I
    Nonaka, I
    Goto, YI
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 329 (05): : 265 - 266
  • [43] A8344G tRNALys mutation associated with recurrent brain stem stroke-like episodes
    Zaganas, Ioannis
    Latsoudis, Helen
    Papadaki, Eufrosini
    Vorgia, Pelagia
    Spilioti, Martha
    Plaitakis, Andreas
    JOURNAL OF NEUROLOGY, 2009, 256 (02) : 271 - 273
  • [44] Hashimoto Encephalopathy Presenting With Stroke-Like Episodes in an Adolescent Female: A Case Report and Literature Review
    Graham, Brett R.
    Shiff, Natalie
    Nour, Munier
    Hasal, Simona
    Huntsman, Richard
    Almubarak, Salah
    PEDIATRIC NEUROLOGY, 2016, 59 : 62 - 70
  • [45] A patient with cerebral Whipple's disease and a stroke-like syndrome
    Famularo, G
    Minisola, G
    De Simone, C
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (05) : 607 - 609
  • [46] Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa
    Abcde, Hsiang-Yu Lin
    Huang, Yu-Hsiu
    Liao, Hsuan-Chieh
    Liu, Hao-Chuan
    Hsu, Ting-Rong
    Shen, Chia-I
    Li, Shao-Tzu
    Li, Cheng-Fang
    Lee, Li-Hong
    Lee, Pi-Chang
    Huang, Chun-Kai
    Chiang, Chuan-Chi
    Lin, Shuan-Pei
    Niu, Dau-Ming
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (04) : 190 - 197
  • [47] Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)
    Tsuboi, Kazuya
    Yamamoto, Hiroshi
    GENETICS IN MEDICINE, 2012, 14 (09) : 779 - 786
  • [48] Successful desensitization of a patient with Fabry disease with agalsidase beta (Fabrazyme) anaphylaxis after omalizumab pretreatment
    DuBuske, Ilona
    Schmidlin, Kristin
    Bernstein, Jonathan A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (01) : 96 - 98
  • [49] SWITCH FROM AGALSIDASE BETA TO AGALSIDASE ALFA IN THE ENZYME REPLACEMENT THERAPY OF PATIENTS WITH FABRY DISEASE IN LATIN AMERICA
    Ripeau, Diego
    Amartino, Hernan
    Cedrolla, Martin
    Urtiaga, Luis
    Urdaneta, Bella
    Cano, Marilis
    Valdez, Rita
    Antongiovanni, Norberto
    Masllorens, Francisca
    MEDICINA-BUENOS AIRES, 2017, 77 (03) : 173 - 179
  • [50] "Clinical Outcomes in Patients Switching From Agalsidase Beta to Migalastat: A Fabry Registry Analysis" (vol 47, no. 5 (2024): 1080)
    Pisan, Antonio
    Wilson, Kathryn M.
    Batista, Julie L.
    Kantola, Ilkka
    Ortiz, Alberto
    Politei, Juan
    Al-Shaar, Laila
    Maski, Manish
    Crespo, Ana
    Ponce, Elvira
    Linhart, Ales
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (02)
12345